DUPIXENT is the first and only biologic treatment for patients aged 6 years and older with uncontrolled moderate-to-severe atopic dermatitis to inhibit the signaling of IL-4 and IL-13, type 2 cytokines.1,2
A Dual Inhibitor of IL-4 and IL-13 Signaling, Administered Via Injection2
When topical prescription therapies are not enough, consider DUPIXENT to help your
appropriate patients who are struggling to control their disease.
Image of an actual patient with atopic dermatitis. Not a clinical trial patient.